Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

US approves “new class” of diabetes drug, under review in Canada

Hanna Lange-Chenier
CMAJ July 09, 2013 185 (10) E470; DOI: https://doi.org/10.1503/cmaj.109-4483
Hanna Lange-Chenier
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 185 no. 10 E470
DOI 
https://doi.org/10.1503/cmaj.109-4483
PubMed 
23734031
History 
  • Published online July 8, 2013.

Article Versions

  • Latest version (June 3, 2013 - 08:38).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2013 Canadian Medical Association or its licensors

Author Information

  1. Hanna Lange-Chenier
  1. CMAJ

Statistics from Altmetric.com

Usage statistics: June 2013 to January 2021

AbstractFullPdf
Jun 201300299
Jul 201306448
Aug 20130615
Sep 20130617
Oct 20131328
Nov 20130244
Dec 20130253
Jan 20140159
Feb 20140179
Mar 20141061
Apr 20140048
May 20140244
Jun 20140042
Jul 20140225
Aug 201401533
Sep 201401622
Oct 201401121
Nov 201401325
Dec 20140816
Jan 2015098
Feb 20150312
Mar 201501523
Apr 20150611
May 2015078
Jun 201501015
Jul 2015095
Aug 201501412
Sep 20150124
Oct 2015095
Nov 20150104
Dec 20150116
Jan 201601313
Feb 2016068
Mar 2016069
Apr 20160614
May 2016008
Jun 20160417
Jul 20160424
Aug 20160717
Sep 2016077
Oct 2016097
Nov 20160616
Dec 20160612
Jan 2017084
Feb 2017010
Mar 2017082
Apr 2017063
May 2017023
Jun 2017067
Jul 2017021
Aug 2017033
Sep 2017062
Oct 2017062
Nov 2017043
Dec 20170171
Jan 2018070
Feb 2018083
Mar 20180100
Apr 20180131
May 20180103
Jun 20180134
Jul 20180103
Aug 2018052
Sep 2018030
Oct 2018051
Nov 2018030
Dec 2018076
Jan 2019020
Feb 2019041
Mar 2019034
Apr 2019034
May 2019023
Jun 2019041
Jul 2019076
Aug 2019031
Sep 2019064
Oct 2019044
Nov 2019041
Dec 2019063
Jan 2020073
Feb 2020098
Mar 2020083
Apr 2020032
May 2020023
Jun 2020030
Jul 2020084
Aug 2020011
Sep 2020088
Oct 20200132
Nov 20200114
Dec 20200114
Jan 2021062
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 185 (10)
CMAJ
Vol. 185, Issue 10
9 Jul 2013
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
US approves “new class” of diabetes drug, under review in Canada
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
US approves “new class” of diabetes drug, under review in Canada
Hanna Lange-Chenier
CMAJ Jul 2013, 185 (10) E470; DOI: 10.1503/cmaj.109-4483

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
US approves “new class” of diabetes drug, under review in Canada
Hanna Lange-Chenier
CMAJ Jul 2013, 185 (10) E470; DOI: 10.1503/cmaj.109-4483
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Trudeau promises to boost federal health transfers when the pandemic is over
  • Does shaming have a place in public health?
  • Should Canada aim for #CovidZero?
Show more News

Similar Articles

Collections

  • Topics
    • Diabetes
    • Canadian government

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire